Trim 30-40% into relief rallies; Underweight warranted by deteriorating momentum and collapsed buybacks despite intact structural thesis
Underweight LRCX with 30-40% trim on relief rallies into $320-330 zone while retaining 50-60% core. The deterioration signals (MACD collapse from +6.48 to +2.21, 50 SMA now actively declining, Q2 buyback collapse 68%) warrant defensive positioning, but intact structural thesis (200 SMA at $252, 65% ROE, 31% net margins, $2.28B deferred revenue, smart money accumulation) prevents full liquidation. Hard stop $282-285 on remaining core. Re-engage only on Option A (breakout above $337.74 with volume confirmation and momentum indicators) or Option B (constructive 200 SMA retest with bullish price action). No new capital deployment at current levels.
| Position | Action |
|---|---|
| Relief rally into $320-330 (10 EMA retest) | Trim 30-40% of LRCX exposure |
| Remaining position after trim | Retain 50-60% core for structural thesis |
| Current levels ($310) | No new capital deployment |
| Daily close below $295 | Immediate position review |
| Daily close below $278 | Additional 30-40% trim |
| Daily close below $268 | Hard stop triggered; full exit review |
Lam Research represents a fundamentally superior business at a technically constructive entry point, with accelerating revenue growth (+30% YoY), expanding margins (37.4% operating), and multiple institutional sponsors, positioned as the primary beneficiary of the largest compute infrastructure buildout in human history.
| Indicator | Value | Signal |
|---|---|---|
| close | $310.53 | neutral |
| close_10_ema | $318.70 | bearish |
| close_50_sma | $337.41 | bearish |
| close_200_sma | $252.58 | bullish |
| rsi | 47.28 | neutral |
| macd | -0.72 | neutral |
| macds | -2.93 | neutral |
| macdh | +2.21 | bullish |
| boll_middle | $307.46 | neutral |
| boll_ub | $350.81 | bearish |
| boll_lb | $264.10 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Constructive retest of 200 SMA at $252 with bullish price action (higher low, positive MACD cross, RSI >40)
Then: Add 50-75% of target weight with stop at $240
↩ rebuts: “Bear's 'competition' argument against Lam Research”
· concedes: Bear's point that 30% growth is off a depressed base is fair, but forward earnings expansion to $11.56 vs $5.74 TTM shows this is not a one-quarter pop; Bear correctly identifies 50-day MA at $337.41 as overhead resistance and negative MACD, but this is normal post-crash consolidation, not a thesis break; Bear's TTM P/E of 54.7x is elevated, but this is a lagging indicator reflecting cycle trough; forward P/E of 27x is on still-growing earnings
LRCX is at a cyclical peak with a 42% crash already in the books, facing permanent China revenue headwinds, customer concentration risk, elevated inventory write-down risk, and deteriorating technicals—the setup is asymmetric to the downside.
· concedes: The bull is correct that Q2 2026 revenue of $6.72B up 30% YoY is a real number; HBM is a legitimate secular demand driver, though limited to 10-15% of DRAM; LRCX's #1 position in etch and #2 in CVD deposition is real competitive advantage; Duquesne, Altimeter, and Druckenmiller rotating into LRCX is a real data point; The 200 SMA at $252.58 did provide support during the worst of the selloff; The Fed being on hold at 85% probability is the base case, providing some multiple stability
→ vs conservative: 200 SMA at $252 did not prevent 42% drawdown from $438; structural uptrend is a lagging indicator confirming what already happened, not predicting what's next
→ vs conservative: Macro backdrop (Fed on hold, 8% recession odds, falling yields) is constructive but AMAT beat got crushed 4% and WFE sold off 5% while S&P rallied—regime divergence precedes multi-month underperformance
→ vs conservative: At 20x $11.56 forward EPS target of $231, conservative 'hold through the cycle' becomes riding position from $310 down to $230
→ vs neutral: MACD histogram 66% collapse in three days is 'momentum failure,' not 'cautiously bullish but fading'—calling it neutral is denial
→ vs neutral: Waiting for 'clean breakout above 50 SMA' at $370+ results in garbage risk/reward; selling now captures deteriorating tape with defined downside
→ vs conservative: Fundamentals report framing 27.2x forward P/E as 'more reasonable' ignores that 27x mid-cycle multiple on potentially peak-cycle earnings compresses quickly on any softness
| atr | 21.08 | neutral |
Support: 264.1 · 252.58 · 295 | Resistance: 318.7 · 337.41 · 350.81
LRCX is recommended as HOLD. Long-term trend is intact (price 23% above 200 SMA at $252.58), but near-term and medium-term trends are bearish (price below both 10 EMA at $318.70 and 50 SMA at $337.41). RSI is neutral at 47.28 with MACD histogram positive at +2.21 but declining from peak +6.48 on Aug 17. ATR has normalized to $21.08 from panic peaks of $28.40+, indicating volatility is moderating. Expected consolidation range is $295 to $337 until a decisive breakout. Existing longs should trim near $337 and maintain stops below $295; new entries should wait for either a confirmed close above $320 with RSI > 55, or a retest of the 200 SMA at $252 as support.
Market Cap
$392.9B
P/E (TTM)
54.7x
Forward P/E
27.2x
P/B
31.5x
PEG Ratio
1.43
EPS (TTM)
$5.74
Forward EPS
$11.56
Dividend Yield
0.33%
52-Week High
$438.50
52-Week Low
$94.11
50-Day MA
$337.44
200-Day MA
$252.83
Beta
1.865
Revenue (TTM)
$23.23B
Gross Margin
50.5%
Operating Margin
37.4%
Net Margin
31.3%
EBITDA
$8.64B
ROE
65.1%
ROA
22.8%
Q2 2026 Revenue
$6,722.2M
Q2 2026 Net Income
$2,277.3M
Q2 2026 Diluted EPS
$1.81
Total Assets
$23.53B
Cash & Equivalents
$5.58B
Total Debt
$3.73B
Net Cash Position
$1.86B
Current Ratio
2.63
Working Capital
$9.67B
Stockholders' Equity
$12.47B
Free Cash Flow (TTM)
$3.09B
FCF Margin
13.3%
Operating Cash Flow (TTM)
$5.86B
Dividends Paid (TTM)
$1.27B
Buybacks (TTM)
$3.85B
Total Returns to Shareholders (TTM)
$5.12B
Share Count Reduction
~18.2M shares (~1.4%)
Forward EPS Growth
+101%
Strengths
Concerns
Lam Research is executing in a textbook semiconductor capital equipment upcycle, with Q2 2026 delivering $6.72B in revenue (+30% YoY) and net income of $2.28B (+32.4% YoY) as AI infrastructure buildout drives HBM memory and advanced logic node demand. The company boasts best-in-class profitability (37.4% operating margin, 65.1% ROE), a fortress balance sheet with $1.86B net cash, and has returned over $5B to shareholders in the trailing twelve months through dividends and buybacks. However, with the stock trading at 54.7x TTM P/E and having rallied substantially from its $94 trough, the forward earnings recovery must materialize to justify the premium valuation and avoid multiple compression in any cyclical downturn.
Macro: Benign macro backdrop with Fed on hold (85% no-cut probability in 2026), low US recession odds (8%), and geopolitical easing (Iran signaling desire to end conflict). Copper rallying to records confirms industrial/AI demand thesis. Chip equipment sold off Aug 19 despite broader market rally and falling Treasury yields — disconnect points to AI-capex digestion rather than macro/rates issue. Risk-on tone with crypto bouncing on US Treasury action; energy mixed late, base metals and gold bid (Morgan Stanley doubling down on gold).